Supernus Announces Repayment of Convertible Notes
ROCKVILLE, Md., April 03, 2023 -- Supernus Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system ... | April 3, 2023